Skip to main content
TipRanks
Go Ultimate75% OFF

Deccan Cements Ltd (DECCANCE) AI Stock Analysis

2 Followers
IN:DECCANCE

Deccan Cements Ltd

(NSE:DECCANCE)

Select Model
Rating:40Underperform
Price Target:INR 461.00â–¼(-4.78% Downside)
Action:reiterated
Date:09/06/26

The overall score is very low, driven primarily by poor financial performance marked by high leverage, negative free cash flow, and weak profitability. An extremely high P/E ratio further weighs on the valuation, while technicals reflect a stock in a medium-term downtrend with neutral short-term momentum.

Positive Factors
FY2026 Revenue ReboundThe FY2026 revenue rebound shows renewed demand for Deccan Cements’ core products after the prior-year weakness. If sustained, stronger sales can improve operating leverage, support capacity utilization, and provide a broader base for rebuilding earnings over the next several quarters.
Negative Factors
Persistently Negative Free Cash FlowPersistently negative free cash flow means reported profitability is not translating into internally generated funding. Continued cash deficits can restrict investment flexibility, increase reliance on external financing, and make it harder to reduce debt or consistently support shareholder distributions.

Deccan Cements Ltd (DECCANCE) vs. iShares MSCI India ETF (INDA)

-50%-40%-30%-20%-10%0%10%IN:DECCANCE-45.16%INDA-5.62%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
INR 6.77B
Dividend Yield
0.10%
Average Volume (3M)
917
Price to Earnings (P/E)
114.3
Beta (1Y)
0.77
Revenue Growth
39.38%
EPS Growth
-70.89%
Country
India
Employees
357
Sector
General
Sector Strength
55
Industry
Construction Materials

Deccan Cements Ltd Business Overview & Revenue Model

Company Description

Deccan Cements Limited engages in the manufacture and sale of cement in India. The company offers ordinary portland, portland pozzolana, and sulphate resistance portland cement products, as well as other specialty cement products, such as rapid harde...

Deccan Cements Ltd Financial Statement Overview

Summary

Financial health is weak. While revenue grew 21%, profitability is depressed (net margin 4.5% vs. >15% historically). High debt-to-equity of 1.0 and deeply negative free cash flow with a low cash flow coverage ratio of 0.16 indicate significant financial strain.

Income Statement

48Neutral

Balance Sheet

35Negative

Cash Flow

25Negative
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue7.04B6.36B5.27B7.99B7.82B7.90B
Gross Profit3.11B2.47B2.61B2.57B4.33B4.06B
EBITDA817.90M971.35M515.70M920.47M1.06B1.62B
Net Income58.43M285.78M75.19M372.63M492.95M875.74M
Balance Sheet
Total Assets017.11B16.25B14.46B11.55B9.85B
Cash, Cash Equivalents and Short-Term Investments905.07M905.07M1.44B2.30B2.12B2.97B
Total Debt07.53B7.14B5.20B2.65B1.66B
Total Liabilities-7.51B9.60B9.03B7.27B4.68B3.39B
Stockholders Equity7.51B7.51B7.22B7.19B6.87B6.46B
Cash Flow
Free Cash Flow-568.13M-1.45B-3.16B-2.34B-1.80B370.50M
Operating Cash Flow392.64M543.17M-376.42M566.99M549.54M792.73M
Investing Cash Flow-923.37M-1.45B-2.27B-2.77B-2.19B-917.43M
Financing Cash Flow368.01M378.28M1.78B2.38B796.52M452.58M

Deccan Cements Ltd Technical Analysis

Technical Analysis SentimentNegative
Last Price484.15

Price Trends

50DMA531.16Negative
100DMA548.26Negative
200DMA596.22Negative

Market Momentum

MACD-16.08Negative
RSI38.23Neutral
STOCH55.53Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:DECCANCE, the sentiment is Negative. The current price of 484.15 is below the 20-day moving average (MA) of 490.37, below the 50-day MA of 531.16, and below the 200-day MA of 596.22, indicating a bearish trend. The MACD of -16.08 indicates Negative momentum. The RSI at 38.23 is Neutral, neither overbought nor oversold. The STOCH value of 55.53 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:DECCANCE.

Deccan Cements Ltd Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:DECCANCE against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IN:SHREDIGCEMIN:SHREDIGCEM45NeutralINR 8.74B-100.96―1.74%32.60%-122.62%
IN:KAKATCEMIN:KAKATCEM42NeutralINR 754.53M-4.14―3.05%-22.00%30.68%
IN:BURNPURIN:BURNPUR41NeutralINR 195.50M-0.34―――27.95%
IN:DECCANCEIN:DECCANCE40UnderperformINR 6.79B114.32―0.10%39.38%-70.89%
IN:ACLIN:ACL40UnderperformINR 3.77B-6.20――72.06%63.74%
IN:SAURASHCEMIN:SAURASHCEM38UnderperformINR 5.49B81.17――7.86%-51.97%

* General Sector Average

Performance Comparison

-60%-40%-20%0%IN:DECCANCEIN:ACLIN:BURNPURIN:KAKATCEMIN:SAURASHCEMIN:SHREDIGCEMDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IN:DECCANCE and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:DECCANCEDeccan Cements Ltd484.15-515.67-51.58%
IN:ACLAndhra Cements Limited40.30-38.70-48.99%
IN:BURNPURBurnpur Cement Limited11.62-21.68-65.11%
IN:KAKATCEMKakatiya Cement Sugar & Industries Ltd.97.06-39.28-28.81%
IN:SAURASHCEMSaurashtra Cement Limited48.60-48.90-50.15%
IN:SHREDIGCEMShree Digvijay Cement Co. Ltd.57.64-31.15-35.08%

Deccan Cements Ltd Corporate Events

Deccan Cements Reports September-Quarter Unaudited Results

Nov 12, 2026

The board on November 12, 2026, approved the unaudited standalone and consolidated financial results for the quarter ended September 30, 2026, along with the related limited review reports. Standalone revenue from operations was Rs 22,168.20 lakh, wh...

Deccan Cements Closes Trading Window Ahead of Q2 FY2026 Results

Sep 25, 2026

Deccan Cements Ltd has announced the closure of its trading window in compliance with SEBI’s Prohibition of Insider Trading Regulations, 2015, covering directors, designated employees, and their immediate relatives. The window will be shut from 1 Oct...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 06, 2026